Adhera Therapeutics, Inc. (ATRX)
OTCMKTS: ATRX · Delayed Price · USD
0.0084
0.00 (0.00%)
Jul 19, 2024, 4:00 PM EDT - Market open
Adhera Therapeutics Employees
Adhera Therapeutics had 2 employees as of December 31, 2022. The number of employees did not change compared to the previous year.
Employees
2
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,264,408
Market Cap
60.66K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2019 | 2 | -22 | -91.67% |
| Dec 31, 2018 | 24 | 17 | 242.86% |
| Dec 31, 2017 | 7 | 3 | 75.00% |
| Dec 31, 2016 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher | 122,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
| Danaher | 63,000 |
ATRX News
- 1 year ago - Adhera Therapeutics to Collaborate with Alberta Diabetes Institute, University of Alberta to Initiate Clinical Trial of MLR-1023 in Type 1 Diabetes - GlobeNewsWire
- 2 years ago - Adhera Therapeutics Announces CEO, Senior Management Changes, Plans for NASDAQ Uplist - GlobeNewsWire
- 2 years ago - Adhera Therapeutics Signs Letter of Intent to Acquire CD71-Targeted Cancer Therapy Paclitaxel Gallium Transferrin - GlobeNewsWire
- 2 years ago - Adhera Therapeutics Appoints Trond K. Waerness as Chairman of the Board, Company Focuses on Uplist to NASDAQ - GlobeNewsWire
- 2 years ago - Adhera Therapeutics Names Preeminent Diabetes Pioneer Dr. Jean Buteau to Scientific Advisory Board - GlobeNewsWire
- 2 years ago - Adhera Therapeutics Announces Uplisting to OTCQB Venture Marketplace - GlobeNewsWire
- 2 years ago - Adhera Therapeutics Receives Notice of Allowance for New Canadian Patent Covering MLR-1019 for Dyskinesia and Related Disorders - GlobeNewsWire
- 2 years ago - Adhera Therapeutics Announces Appointment of Dr. Zahed Subhan to Board of Directors - GlobeNewsWire